Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	1 Months Ended	2 Months Ended	3 Months Ended
	Feb. 02, 2021	Mar. 31, 2021	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ 268,777	$ (36,630)	$ 25,726
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation, depletion, amortization and accretion	10,499	52,805	34,085
Deferred income taxes	54,322	(5,051)	(2,769)
Amortization of Credit Facility Costs	0	82	127
Stock-based compensation expense	935	0	585
Reorganization items, net	(354,279)	0	0
Bad debt	(210)	(4,398)	(1,203)
Gain on sale of assets and businesses	58	0	0
Gain on sale of equity securities	0	0	(1,761)
Unrealized gain on investment in equity securities	0	0	(6,474)
Other gains and losses, net	0	(2,669)	(5,755)
Other reconciling items, net	1,017	(246)	(1)
Changes in operating assets and liabilities:
Accounts receivable	3,602	2,414	(13,359)
Prepaid expense	(340)	(4,625)	(176)
Inventory and other current assets	(221)	2,496	1,562
Accounts payable	(2,365)	4,592	3,888
Accrued expenses	23,489	9,857	(3,673)
Income taxes	340	5,134	4,239
Other, net	(241)	(2,360)	(49)
Net cash provided by operating activities	5,383	21,401	35,090
Cash flows from investing activities:
Payments for capital expenditures	(3,035)	(4,119)	(11,297)
Proceeds from sales of assets	775	7,148	13,379
Proceeds from sales of equity securities	0	0	7,365
Net cash from investing activities	(2,260)	3,029	9,447
Cash flows from financing activities:
Credit facility costs	(1,920)	(14)	0
Net cash from financing activities	(1,920)	(14)	0
Effect of exchange rate changes on cash	311	0	0
Net change in cash, cash equivalents, and restricted cash	1,514	24,416	44,537
Cash, cash equivalents, and restricted cash beginning of period		269,698	394,535
Cash, cash equivalents, and restricted cash at end of period	$ 269,698	$ 294,114	$ 439,072